← All trials
NCT01726088
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2012
- Primary completion
- May 1, 2013
- Completion date
- May 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Biomedical Research FoundationLead sponsor
- Department of Veteran AffairsOverall official - principal investigator
- National Center for Research Resources (NCRR)Collaborator
- National Institute of General Medical Sciences (NIGMS)Collaborator
- Biomedical Research FoundationReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.